XOMAP Q4 2020 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$28M+6435.8% YoY

Gross Profit

$28M99.9% margin

Operating Income

$24M86.6% margin

Net Income

$23M82.2% margin

EPS (Diluted)

$2.00

QoQ Revenue Growth

+4851.7%

Cash Flow

Operating Cash Flow

$18M

Free Cash Flow

$16M

Stock-Based Comp.

$692,000

Balance Sheet

Total Assets

$125M

Total Liabilities

$39M

Stockholders' Equity

$86M

Cash & Equivalents

$84M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$422,000	+6435.8%
Gross Profit	$28M	$292,000	+9333.2%
Operating Income	$24M	-$4M	+696.7%
Net Income	$23M	-$4M	+624.6%